A citation-based method for searching scientific literature

Tomoko Shofuda, Yonehiro Kanemura. Neuro Oncol 2021
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential.
Alexandre Perla, Lívia Fratini, Paula S Cardoso, Carolina Nör, André T Brunetto, Algemir L Brunetto, Caroline Brunetto de Farias, Mariane Jaeger, Rafael Roesler. Front Cell Dev Biol 2020
14
66

DNA methylation-based classification of central nervous system tumours.
David Capper, David T W Jones, Martin Sill, Volker Hovestadt, Daniel Schrimpf, Dominik Sturm, Christian Koelsche, Felix Sahm, Lukas Chavez, David E Reuss,[...]. Nature 2018
66

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
66


Current approaches in identification and isolation of cancer stem cells.
Maryam Akbarzadeh, Nazila Fathi Maroufi, Abbas Pirpour Tazehkand, Moloud Akbarzadeh, Sepideh Bastani, Reza Safdari, Ali Farzane, Amir Fattahi, Hamid Reza Nejabati, Mohammad Nouri,[...]. J Cell Physiol 2019
38
33

Revealing the glioma cancer stem cell interactome, one niche at a time.
Daniel J Silver, Justin D Lathia. J Pathol 2018
21
33

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Dagmar Beier, Peter Hau, Martin Proescholdt, Annette Lohmeier, Jörg Wischhusen, Peter J Oefner, Ludwig Aigner, Alexander Brawanski, Ulrich Bogdahn, Christoph P Beier. Cancer Res 2007
841
33

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, Thomas Zichner, Adrian M Stütz, Serap Erkek, Daisuke Kawauchi, David J H Shih, Volker Hovestadt, Marc Zapatka, Dominik Sturm,[...]. Nature 2014
357
33

Cancer. New epigenetic drivers of cancers.
Simon J Elsässer, C David Allis, Peter W Lewis. Science 2011
49
33

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
Brian B Liau, Cem Sievers, Laura K Donohue, Shawn M Gillespie, William A Flavahan, Tyler E Miller, Andrew S Venteicher, Christine H Hebert, Christopher D Carey, Scott J Rodig,[...]. Cell Stem Cell 2017
223
33


Epigenetic Modification and Differentiation Induction of Malignant Glioma Cells by Oligo-Fucoidan.
Chien-Huang Liao, I-Chun Lai, Hui-Ching Kuo, Shuang-En Chuang, Hsin-Lun Lee, Jacqueline Whang-Peng, Chih-Jung Yao, Gi-Ming Lai. Mar Drugs 2019
10
33

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner, Jeremy N Rich. Nature 2006
33


CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.
A Lujambio, A Portela, J Liz, S A Melo, S Rossi, R Spizzo, C M Croce, G A Calin, M Esteller. Oncogene 2010
137
33

HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
Mariane da Cunha Jaeger, Eduarda Chiesa Ghisleni, Paula Schoproni Cardoso, Marialva Siniglaglia, Tiago Falcon, André T Brunetto, Algemir L Brunetto, Caroline Brunetto de Farias, Michael D Taylor, Carolina Nör,[...]. J Mol Neurosci 2020
13
33

Epigenetics in cancer: targeting chromatin modifications.
Leigh Ellis, Peter W Atadja, Ricky W Johnstone. Mol Cancer Ther 2009
325
33

Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing.
Alba Rodriguez-Meira, Gemma Buck, Sally-Ann Clark, Benjamin J Povinelli, Veronica Alcolea, Eleni Louka, Simon McGowan, Angela Hamblin, Nikolaos Sousos, Nikolaos Barkas,[...]. Mol Cell 2019
104
33

Global DNA hypomethylation in cancer: review of validated methods and clinical significance.
Estela G Toraño, Sandra Petrus, Agustin F Fernandez, Mario F Fraga. Clin Chem Lab Med 2012
65
33

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
Rossella Galli, Elena Binda, Ugo Orfanelli, Barbara Cipelletti, Angela Gritti, Simona De Vitis, Roberta Fiocco, Chiara Foroni, Francesco Dimeco, Angelo Vescovi. Cancer Res 2004
33

DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology.
Raúl Alelú-Paz, Nadia Ashour, Ana González-Corpas, Santiago Ropero. J Signal Transduct 2012
17
33

Vorinostat-An Overview.
Aditya Kumar Bubna. Indian J Dermatol 2015
51
33


Nonhistone protein acetylation as cancer therapy targets.
Brahma N Singh, Guanghua Zhang, Yi L Hwa, Jinping Li, Sean C Dowdy, Shi-Wen Jiang. Expert Rev Anticancer Ther 2010
196
33

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Enli Yang, Xuan Wang, Zhiyuan Gong, Miao Yu, Haiwei Wu, Dongsheng Zhang. Signal Transduct Target Ther 2020
66
33

Histone Deacetylase Inhibitors as Anticancer Drugs.
Tomas Eckschlager, Johana Plch, Marie Stiborova, Jan Hrabeta. Int J Mol Sci 2017
572
33

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
Joyce E Ohm, Kelly M McGarvey, Xiaobing Yu, Linzhao Cheng, Kornel E Schuebel, Leslie Cope, Helai P Mohammad, Wei Chen, Vincent C Daniel, Wayne Yu,[...]. Nat Genet 2007
787
33

The roles of microRNAs in epigenetic regulation.
Qian Yao, Yuqi Chen, Xiang Zhou. Curr Opin Chem Biol 2019
133
33

Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
Dan Zhou, Bonnie M Alver, Shuang Li, Ryan A Hlady, Joyce J Thompson, Mark A Schroeder, Jeong-Heon Lee, Jingxin Qiu, Philip H Schwartz, Jann N Sarkaria,[...]. Genome Biol 2018
48
33

Identification of a cancer stem cell in human brain tumors.
Sheila K Singh, Ian D Clarke, Mizuhiko Terasaki, Victoria E Bonn, Cynthia Hawkins, Jeremy Squire, Peter B Dirks. Cancer Res 2003
33

Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma.
Michaël H Meel, Mark C de Gooijer, Dennis S Metselaar, A Charlotte P Sewing, Kenn Zwaan, Piotr Waranecki, Marjolein Breur, Levi C M Buil, Tonny Lagerweij, Laurine E Wedekind,[...]. Clin Cancer Res 2020
23
33


microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide.
Fermino Sanches Lizarte Neto, Andressa Romualdo Rodrigues, Felipe Amstalden Trevisan, Mucio Luiz de Assis Cirino, Caio César Marconato Simões Matias, Gabriela Pereira-da-Silva, Fernanda Maris Peria, Daniela Pretti da Cunha Tirapelli, Carlos Gilberto Carlotti. Brain Res 2019
5
33

Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.
Gi-Jun Sung, Sung-Hak Kim, Sungmin Kwak, Seung-Ho Park, Ji-Hye Song, Ji-Hoon Jung, Hyunhee Kim, Kyung-Chul Choi. J Pineal Res 2019
21
33

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
Barbara Banelli, Elisa Carra, Federica Barbieri, Roberto Würth, Federica Parodi, Alessandra Pattarozzi, Roberta Carosio, Alessandra Forlani, Giorgio Allemanni, Daniela Marubbi,[...]. Cell Cycle 2015
65
33

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B Baylin. Mol Cell 2014
531
33

The role of CD133 in cancer: a concise review.
Paige M Glumac, Aaron M LeBeau. Clin Transl Med 2018
149
33

The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.
Evelina Miele, Sergio Valente, Vincenzo Alfano, Marianna Silvano, Paolo Mellini, Diana Borovika, Biagina Marrocco, Agnese Po, Zein Mersini Besharat, Giuseppina Catanzaro,[...]. Oncotarget 2017
27
33

Clinical Toxicities of Histone Deacetylase Inhibitors.
Srividya Subramanian, Susan E Bates, John J Wright, Igor Espinoza-Delgado, Richard L Piekarz. Pharmaceuticals (Basel) 2010
196
33

Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells.
Siqin Bao, Fuchou Tang, Xihe Li, Katsuhiko Hayashi, Astrid Gillich, Kaiqin Lao, M Azim Surani. Nature 2009
286
33

Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth.
Evelina Miele, Agnese Po, Angela Mastronuzzi, Andrea Carai, Zein Mersini Besharat, Natalia Pediconi, Luana Abballe, Giuseppina Catanzaro, Claudia Sabato, Enrico De Smaele,[...]. Mol Oncol 2021
4
33

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
George R Blumenschein, Merrill S Kies, Vassiliki A Papadimitrakopoulou, Charles Lu, Ashok J Kumar, Justin L Ricker, Judy H Chiao, Cong Chen, Stanley R Frankel. Invest New Drugs 2008
139
33

Biophysical regulation of epigenetic state and cell reprogramming.
Timothy L Downing, Jennifer Soto, Constant Morez, Timothee Houssin, Ashley Fritz, Falei Yuan, Julia Chu, Shyam Patel, David V Schaffer, Song Li. Nat Mater 2013
282
33

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
F Orzan, S Pellegatta, P L Poliani, F Pisati, V Caldera, F Menghi, D Kapetis, C Marras, D Schiffer, G Finocchiaro. Neuropathol Appl Neurobiol 2011
98
33

Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.
Sergio Valente, Yiwei Liu, Michael Schnekenburger, Clemens Zwergel, Sandro Cosconati, Christina Gros, Maria Tardugno, Donatella Labella, Cristina Florean, Steven Minden,[...]. J Med Chem 2014
66
33

Cancer stem cells: impact, heterogeneity, and uncertainty.
Jeffrey A Magee, Elena Piskounova, Sean J Morrison. Cancer Cell 2012
795
33

FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Branavan Manoranjan, Xin Wang, Robin M Hallett, Chitra Venugopal, Stephen C Mack, Nicole McFarlane, Sara M Nolte, Katrin Scheinemann, Thorsteinn Gunnarsson, John A Hassell,[...]. Stem Cells 2013
41
33

Identification of human brain tumour initiating cells.
Sheila K Singh, Cynthia Hawkins, Ian D Clarke, Jeremy A Squire, Jane Bayani, Takuichiro Hide, R Mark Henkelman, Michael D Cusimano, Peter B Dirks. Nature 2004
33

Cancer stem cell surface markers on normal stem cells.
Won-Tae Kim, Chun Jeih Ryu. BMB Rep 2017
138
33

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.
Tatyana N Ignatova, Valery G Kukekov, Eric D Laywell, Oleg N Suslov, Frank D Vrionis, Dennis A Steindler. Glia 2002
706
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.